Announcements A Joint Statement on Technical, legal, ethical and implementation concerns regarding Aarogya Setu and other apps introduced during COVID-19 in India by Jan Swasthya Abhiyan (JSA), Internet Freedom Foundation (IFF), Forum for Medical Ethics Society (FMES), and All India People’s Science Network (AIPSN)   |   Submission to the National Human Rights Commission (NHRC) on behalf of Hub5 (HEaL Institute, APU, Seher-CHSJ, and IAPH) – COPASAH on human rights issues confronted by ASHAS and ANMs during the Covid-19 pandemic | Aug 7, 2020   |   Letter to MMC by FMES, PUCL-MH, FAOW, and MFC urging to restore its order suspending licenses of two doctors accused of abetting the suicide of Dr Payal Tadvi

Sources of information in drug advertisements: Evidence from the drug indexing journal of Bangladesh

Mohammad Saidul Islam, Sharmin Shams Farah

DOI: 10.20529/IJME.2008.049


Drug advertisements often lack scientific evidence to support their claims. This descriptive study was conducted to measure the sources of information in drug advertisements in Bangladesh. Advertisements containing at least one medical or pharmaceutical claim were extracted from a convenience sample of the second issue of MediMedia Index of Medical Specialities (MIMS) Bangladesh in 2006. Descriptive statistical analyses including frequency distribution and percentage were performed for data analysis. Of the total 112 advertisements about 82 per cent did not provide any references in support of their claims. Only 17.9 per cent did; of which 65 per cent of the references included journal articles, which was followed by “data on file” in 25 per cent of cases. Superlative claims were commonly used without any scientific evidence. The study reported that medical or pharmaceutical claims made in the drug advertisements in MIMS Bangladesh are mostly not supported by scientific evidence.

Full Text





There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US